PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tıbbi Farmakoloji Anabilim Dalı, Tıp Fakültesi, Çukurova Üniversitesi, Sarıçam, Adana, Turkey. zakirkhan300@gmail.com.\', \'Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan. zakirkhan300@gmail.com.\', \'Tıbbi Farmakoloji Anabilim Dalı, Tıp Fakültesi, Çukurova Üniversitesi, Sarıçam, Adana, Turkey.\', \'Pharmacovigilance specialist, Balcalı Hospital, Cukurova University, Adana, Turkey.\', \'Department of Microbiology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan (AWKUM), Mardan, KPK, Pakistan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12325-020-01351-9
?:doi
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 32350686
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32350686>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32350686>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all